ACADIA PHARMACEUTICALS INC (ACAD)
US0042251084 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 484.1M 9.57% | 517.2M 6.84% | 726.437M 40.46% | 997.66M 37.34% | 1.07B 7.25% | 1.183B 10.56% | 1.29B 9.04% | 1.413B 9.53% | 1.448B 2.48% | 1.471B 1.59% | 1.547B 5.17% | |
| EBITDA YoY % growth | -167.05M 41.11% | -221.57M -32.64% | -67.827M 69.39% | 121.19M 278.68% | 133.62M 10.26% | 212.97M 59.38% | 685.13M 221.70% | 813.25M 18.70% | N/A | N/A | N/A | |
| EBIT YoY % growth | -170.4M 40.54% | -223.6M -31.22% | -73.379M 67.18% | 120.48M 264.19% | 128.7M 6.82% | 191.41M 48.73% | 288.01M 50.47% | 386.01M 34.03% | 379.67M -1.64% | 405.19M 6.72% | 433.2M 6.91% | |
| Operating Margin | -35.20% | -43.23% | -10.10% | 12.08% | 12.03% | 16.18% | 22.33% | 27.32% | 26.22% | 27.55% | 28.00% | |
| EPS YoY % growth | -1.05 41.67% | -0.97 7.62% | -0.38 60.82% | 0.72 289.70% | 0.78 7.97% | 1.16 49.39% | 1.80 55.14% | 2.35 30.45% | 1.91 -18.73% | 2.39 25.07% | 2.61 9.31% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.25 -10.08% | 0.04 -59.20% | 0.16 -19.67% | 0.17 -14.58% | 0.24 -3.35% |
| Revenue Q2Q % growth | 288.58M 24.90% | 237.33M 15.30% | 262.09M 8.32% | 270.88M 8.18% | 277.28M -3.92% |
| EBITDA Q2Q % growth | 32.518M -19.70% | 11.118M -46.39% | 33.456M -13.18% | 38.352M -9.36% | 38.148M 17.31% |
| EBIT Q2Q % growth | 43.852M 25.49% | 3.827M -74.84% | 27.814M -8.62% | 29.866M -5.62% | 45.003M 2.62% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 0.20 150.00% | 0.14 | 0.06 | 41.97% |
| Q2 2024 Q2Q % growth | 0.20 1,900.00% | 0.18 | 0.02 | 9.83% |
| Q1 2024 Q2Q % growth | 0.10 137.04% | 0.05 | 0.05 | 109.49% |
| Q4 2023 Q2Q % growth | 0.28 207.69% | 0.31 | -0.03 | -9.66% |
| Q3 2023 Q2Q % growth | -0.40 -135.29% | -0.43 | 0.03 | 7.97% |
| Q2 2023 Q2Q % growth | 0.01 104.76% | -0.08 | 0.09 | 111.87% |
| Q1 2023 Q2Q % growth | -0.27 18.18% | -0.22 | -0.05 | -23.29% |
| Q4 2022 Q2Q % growth | -0.26 3.70% | -0.25 | -0.01 | -4.94% |
| Q3 2022 Q2Q % growth | -0.17 -88.89% | -0.19 | 0.02 | 12.05% |
| Q2 2022 Q2Q % growth | -0.21 22.22% | -0.25 | 0.04 | 16.87% |
| Q1 2022 Q2Q % growth | -0.33 21.43% | -0.61 | 0.28 | 46.18% |
| Q4 2021 Q2Q % growth | -0.27 35.71% | -0.24 | -0.03 | -11.34% |
| Q3 2021 Q2Q % growth | -0.09 83.33% | -0.27 | 0.18 | 66.19% |
| Q2 2021 Q2Q % growth | -0.27 | -0.31 | 0.04 | 13.13% |
| Q1 2021 Q2Q % growth | -0.42 26.32% | -0.54 | 0.12 | 22.52% |
| Q4 2020 Q2Q % growth | -0.42 -23.53% | -0.48 | 0.06 | 12.68% |
| Q3 2020 Q2Q % growth | -0.54 -86.21% | -0.39 | -0.15 | -38.11% |
| Q2 2020 Q2Q % growth | -0.27 28.95% | -0.45 | 0.18 | 40.17% |
| Q1 2020 Q2Q % growth | -0.57 3.39% | -0.49 | -0.08 | -16.35% |
| Q4 2019 Q2Q % growth | -0.34 32.00% | -0.37 | 0.03 | 8.14% |
| Q3 2019 Q2Q % growth | -0.29 42.00% | -0.41 | 0.12 | 29.19% |
| Q2 2019 Q2Q % growth | -0.38 25.49% | -0.46 | 0.08 | 18.04% |
| Q1 2019 Q2Q % growth | -0.59 -34.09% | -0.54 | -0.05 | -10.27% |
| Q4 2018 Q2Q % growth | -0.50 | -0.56 | 0.06 | 10.87% |
| Q3 2018 Q2Q % growth | -0.50 | -0.59 | 0.09 | 15.19% |
| Q2 2018 Q2Q % growth | -0.51 | -0.46 | -0.05 | -10.57% |
| Q1 2018 Q2Q % growth | -0.44 | -0.56 | 0.12 | 21.36% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 250.401M 18.28% | 253.79M | -3.389M | -1.34% |
| Q2 2024 Q2Q % growth | 241.963M 46.44% | 240.37M | 1.593M | 0.66% |
| Q1 2024 Q2Q % growth | 205.831M 73.75% | 212.46M | -6.629M | -3.12% |
| Q4 2023 Q2Q % growth | 231.041M 69.26% | 228.26M | 2.781M | 1.22% |
| Q3 2023 Q2Q % growth | 211.699M 61.97% | 193.28M | 18.419M | 9.53% |
| Q2 2023 Q2Q % growth | 165.235M 22.76% | 160.96M | 4.275M | 2.66% |
| Q1 2023 Q2Q % growth | 118.462M 2.56% | 122.69M | -4.228M | -3.45% |
| Q4 2022 Q2Q % growth | 136.5M 4.36% | 136.75M | -250K | -0.18% |
| Q3 2022 Q2Q % growth | 130.7M -0.68% | 141.42M | -10.72M | -7.58% |
| Q2 2022 Q2Q % growth | 134.6M 16.84% | 133.04M | 1.56M | 1.17% |
| Q1 2022 Q2Q % growth | 115.5M 8.35% | 124.35M | -8.85M | -7.12% |
| Q4 2021 Q2Q % growth | 130.8M 8.10% | 138.1M | -7.3M | -5.29% |
| Q3 2021 Q2Q % growth | 131.6M 9.12% | 130.31M | 1.29M | 0.99% |
| Q2 2021 Q2Q % growth | 115.2M 4.63% | 127.44M | -12.24M | -9.60% |
| Q1 2021 Q2Q % growth | 106.6M 18.31% | 113.87M | -7.27M | -6.38% |
| Q4 2020 Q2Q % growth | 121M 23.09% | 125.67M | -4.67M | -3.72% |
| Q3 2020 Q2Q % growth | 120.6M 27.48% | 121.2M | -600K | -0.50% |
| Q2 2020 Q2Q % growth | 110.1M 32.33% | 105.41M | 4.69M | 4.45% |
| Q1 2020 Q2Q % growth | 90.1M 43.02% | 92.894M | -2.794M | -3.01% |
| Q4 2019 Q2Q % growth | 98.3M 64.93% | 98.698M | -398K | -0.40% |
| Q3 2019 Q2Q % growth | 94.6M 62.26% | 90.257M | 4.343M | 4.81% |
| Q2 2019 Q2Q % growth | 83.2M 45.71% | 73.568M | 9.632M | 13.09% |
| Q1 2019 Q2Q % growth | 63M 28.83% | 61.901M | 1.099M | 1.78% |
| Q4 2018 Q2Q % growth | 59.6M | 60.653M | -1.053M | -1.74% |
| Q3 2018 Q2Q % growth | 58.3M | 57.187M | 1.113M | 1.95% |
| Q2 2018 Q2Q % growth | 57.1M | 59.805M | -2.705M | -4.52% |
| Q1 2018 Q2Q % growth | 48.9M | 47.184M | 1.716M | 3.64% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 128.77% | 31.3% | 24.41% | 35.65% |
| Revenue | 6.64% | 7.94% | 1.14% | 2.73% |